Stephen L. Chan
0000-0001-8998-5480
Publication & Citation Trends
Publications
0 total
Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naive Advanced Hepatocellular Carcinoma: Long-Term Follow-Up of Open-Label, Phase 2 KEYNOTE-224 Study.
Cited by 0
Semantic Scholar
Transarterial Chemoembolization and Immunotherapy: Another Good Marriage?
Cited by 0
Semantic Scholar
Impact of Age on Patient-Reported Outcomes with First-Line Camrelizumab plus Rivoceranib versus Sorafenib in Adults With Unresectable Hepatocellular Carcinoma: Post hoc Analyses of the CARES-310 Open-label, Randomized, Phase 3 Trial
Cited by 0
Semantic Scholar
Prognostic implications of tumour number in intrahepatic cholangiocarcinoma
Cited by 0
Semantic Scholar
Letter: Recurrence pattern for HBV-related HCC after liver transplantation in the antiviral era. Authors' reply.
Cited by 0
Semantic Scholar
Systemic Therapy for Advanced Hepatocellular Carcinoma in 2026: Current Standard‐of‐Care and Emerging Therapeutic Strategies
Cited by 0
Semantic Scholar
Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab.
Cited by 0
Semantic Scholar
Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study
Cited by 0
Semantic Scholar
Research Topics
Hepatocellular Carcinoma Treatment and Prognosis
(287)
Liver Disease Diagnosis and Treatment
(108)
Cancer Immunotherapy and Biomarkers
(100)
Pancreatic and Hepatic Oncology Research
(98)
Cholangiocarcinoma and Gallbladder Cancer Studies
(66)
Affiliations
James S. McDonnell Foundation
University of London
Western University
Hospital Authority
St George's Hospital